Gattefossé celebrated the grand opening of its new manufacturing facility in Lufkin, TX. The inauguration attracted local and national officials including Congressman Pete Sessions and Mayor Mark Hicks, as well as Gattefossé executives, customers, partners, employees and community members. According to Gattefossé, the move represents a milestone in Gattefossé’s global growth strategy, expanding its production capabilities in North America and reinforces its position as a top international supplier.

With the inauguration of the Texas site, Gattefossé has manufacturing sites in the North America, Asia (Singapore) and Europe (France). This global network ensures resilient supply chains, greater proximity to customers and consistent product quality worldwide, according to company executives.

The Lufkin plant is dedicated to lipid-based excipients. It’s design has the dual ambition of increasing production capacity and reinforcing Gattefossé’s presence in North America. Customers at the event liked what they saw.

“Our partnership with Gattefossé is rooted in history, shaped by science and built on trust,” said Diana Trepanier, VP-procurement, pharma and consumer health, Catalent. “This new, US-based footprint is more than an operational expansion. It’s a powerful lever for performance. By locating closer to our development sites and manufacturing hubs, Gattefossé reduces supply risk, strengthens resilience and ensures real-time collaboration. In our fast-moving world, proximity isn’t a convenience, it’s a competitive advantage. This investment tells the world that Gattefossé is scaling with purpose and strengthening the reliability and quality of the entire supply chain.”

World-Class Certifications

Founded in 1880 with corporate headquarters in Lyon, France, Gattefossé develops innovative natural ingredients. The company opened offices in Paramus, NJ in 1982. Gattefossé opened a technical center of excellence in 2017.

“The opening of our new plant in Lufkin marks a major milestone in our company’s journey. This investment is not about short-term gain. It is about building a foundation that will serve our customers for decades to come,” said Ségoléne Moyrand-Gros, president, Gattefossé Group. “Choosing the United States was a strategic decision. This region is not only a leading market, but also a key driver of global trends in pharmaceuticals and personal care. This plant is more than a building; it is a promise to grow, to innovate and to create value together with confidence, responsibility and passion.”

The Lufkin facility is the most significant investment in the Group’s history. It was conceived as a long-term commitment to customers. It offers increased production capacity, secured supply chains and optimized lead times. At the same time, maintaining the same high-quality standards delivered around the world.

In March, 2025, the Lufkin plant was awarded three world-class certifications—ISO 9001, EFICI GMP and Excipact. The certifications recognize Gattefossé’s rigorous approach to quality, safety and compliance in both pharmaceutical and cosmetic ingredients manufacturing. The site was awarded LEED certification, ensuring it meets the highest environmental standards.